Improve-it trial summary

Author: uxzl

August undefined, 2024

Witryna[The IMPROVE-IT trial] [The IMPROVE-IT trial] [The IMPROVE-IT trial] G Ital Cardiol (Rome). 2015 Dec;16(12):667-71. doi: 10.1714/2088.22578. [Article in Italian] Authors … WitrynaOther trials have shown that digital adherence technologies (SMS-based and those based on medication event reminder monitors), implemented in real-time, can improve successful treatment outcomes. It is important, though, to understand the cost of delivering such interventions and also how these can be implemented in routine practice.

Understanding IMPROVE-IT and the cardinal role of LDL-C …

Witryna19 lis 2014 · Con IMPROVE IT finalmente ha aparecido el estudio clínicamente relevante sobre la reducción de los niveles de colesterol con ezetimibe añadido a una estatina (simvastatina, estatina de moderada intensidad según las guías mencionadas), en el que se ha demostrado una mejoría pronóstica a pesar de partir con unos niveles LDL … WitrynaTrial Summary: Opioid vs NonopioidSingle Dose Medications for Acute Extremity Pain in the Emergency Department (ED) May 2024 Opioid Tapering Q&A Patient Booklet Apr 2024 Non-Live Recombinant Herpes Zoster Vaccine (SHINGRIX) 2024 Nov 2024 Exercise Rx(pdf) Nov 2024 Exercise Rx(Word) Nov 2024 solarwinds tftp server manual

Digital adherence technologies to improve tuberculosis treatment ...

Witryna7 lis 2014 · The IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) is a true cardiovascular outcomes trial and was designed to test the … Witryna20 wrz 2005 · Brief Summary: This is a randomized, active-control, double-blind study of subjects with stabilized high-risk acute coronary syndrome (ACS). The primary … WitrynaThe results of the IMPROVE-IT trial are fostering new debate about the value of adjunctive low-density lipoprotein cholesterol lowering over and above a statin. Summary Ezetimibe / simvastatin combination, either as a single pill or as the combined use of the individual compounds, represents a well-tolerated and efficacious choice for ... solarwinds tftp server software

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

Mortality and other 30-day outcomes in the IMPROVE …

Witryna3 lut 2024 · Lay Summary Non-Hispanic Black Americans experience the highest, and most rapidly increasing, rates of obesity and diseases attributed at least in part to poor diet quality. In contrast to restrictive diets, which can be ineffective and often harmful, there is a well-established connection between home cooking and lower body mass … Witryna18 cze 2015 · When added to statin therapy, ezetimibe resulted in incremental lowering of LDL cholesterol levels and improved cardiovascular outcomes. Moreover, lowering LDL cholesterol to levels below previous targets provided additional benefit. (Funded by Merck; IMPROVE-IT ClinicalTrials.gov number, NCT0020287 … slytherin hogwarts trunksWitryna1 maj 2016 · Recent findings: IMPROVE-IT is the first trial that demonstrates a significant clinical benefit of a nonstatin hypolipidemic agent (ezetimibe) used in combination with statin (simvastatin)... slytherin home screen

"Witryna10 cze 2014 · It is predicted, therefore, the trial will complete in 2014. IMPROVE-IT when reported will be the largest and longest contemporary trial focusing specifically on … " - Improve-it trial summary

Improve-it trial summary

IMPROVE-IT: Ezetimibe/Simvastatin vs. Simvastatin Monotherapy …

Witryna1 wrz 2024 · This trial is registered at ClinicalTrials.gov, NCT00125593, and ISRCTN54137607. 4650 patients were assigned to receive simvastatin plus ezetimibe and 4620 to placebo. Witryna2 lis 2024 · IMPROVE-IT was a multinational, double-blind, randomised, placebo-controlled trial that enrolled 18 144 patients who had been stabilised after an acute coronary syndrome. Recruitment was from Oct 26, 2005, to July 8, 2010, and the trial reported its primary outcome in June, 2015. The trial was done in 1158 sites in 39 …

Did you know?

WitrynaIMPROVE-IT TRIAL; Problem: Recent acute coronary syndrome with raised LDL: Format: Double-blind RCT: Treatment: Ezetimibe 10mg + Simvastatin 40mg: Control: … WitrynaIMPROVE-IT（Improved Reduction of Outcomes: Vytorin Efficacy International Trial [进一步降低终点事件：葆至能疗效国际试验]）是一项在急性冠脉综合征的高危患者中 …

Witryna11 kwi 2024 · The aim of a lay summary is not only to enhance understanding of complex medical information, but also to increase transparency in clinical research. 1 This effort is supported by an increasing interest of study participants in study results and call for greater transparency. 2 Providing a lay summary for all clinical trials – … Witryna1 maj 2016 · Recent findings: IMPROVE-IT is the first trial that demonstrates a significant clinical benefit of a nonstatin hypolipidemic agent (ezetimibe) used in …

WitrynaRationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of … Witryna17 lis 2014 · A. Adding ezetimibe, a non-statin agent, to statin therapy reduces cardiovascular events in high-risk patients with acute coronary syndrome (ACS), according to results of the IMPROVE-IT Trial presented Nov. 17 at AHA 2014. The study was led by Christopher P. Cannon, MD, FACC, professor of medicine at Harvard …

WitrynaThe Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) evaluated the effect of ezetimibe combined with simvastatin, as compared with that of simvastatin alone, in...

Witryna10 lis 2024 · These considerations led to the design of the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial (REDUCE-IT). 15 Icosapent ethyl is a … solarwinds velocloud monitoringWitryna12 kwi 2015 · The IMPROVE-IT trial, launched 9 years ago, has finally provided physicians with long-term efficacy and safety evidence for ezetimibe. The large-scale … solarwinds tftp server freeWitrynaThe IMPROVE trial was more ‘real world’ but has been criticised for including participants who did not have a ruptured aneurysm or who died before repair could be accomplished. This serves to highlight the … slytherin holiday sweaterWitryna19 lis 2014 · IMPROVE IT posiblemente inducirá algún cambio en las guías en futuras revisiones. Otra posibilidad es que pueda ayudar a evitar la posibilidad de … solarwinds unable to start pollingWitryna1 lis 2008 · The IMPROVE-IT trial has become even more important since the release of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial results, 24 which compared the effects the combination of ezetimibe and high-dose simvastatin with high-dose simvastatin alone on carotid … solarwinds voip \u0026 network quality managerWitrynaplacebo‐controlled trial design, the benefit could have been due to the statin alone. SHARP What IMPROVE‐IT may add? Ezetimibe may modestly lower CV event risk … solarwinds tftp server windows firewallWitryna27 lis 2014 · The IMPROVE-IT trial (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial) by Dharam Kumbhani MD, and colleagues studied the safety and … solarwinds that full control